BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

968 related articles for article (PubMed ID: 19028425)

  • 1. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity.
    Xie F; Zhao H; Zhao L; Lou L; Hu Y
    Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anticancer activity of novel tetralin-6-ylpyridine and tetralin-6-ylpyrimidine derivatives.
    Amin KM; El-Zahar MI; Anwar MM; Kamel MM; Mohamed MH
    Acta Pol Pharm; 2009; 66(3):279-91. PubMed ID: 19645328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents.
    Rostom SA; Ashour HM; Abd El Razik HA
    Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-component, one-pot synthesis of 2,4,5-substituted pyrimidines library for screening against human hepatocellular carcinoma BEL-7402 cells.
    Xie F; Li S; Bai D; Lou L; Hu Y
    J Comb Chem; 2007; 9(1):12-3. PubMed ID: 17206826
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines.
    Fahmy HT; Rostom SA; Saudi MN; Zjawiony JK; Robins DJ
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):216-25. PubMed ID: 12916055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiviral and cytostatic evaluations of the new C-5 substituted pyrimidine and furo[2,3-d]pyrimidine 4',5'-didehydro-L-ascorbic acid derivatives.
    Gazivoda T; Sokcević M; Kralj M; Suman L; Pavelić K; De Clercq E; Andrei G; Snoeck R; Balzarini J; Mintas M; Raić-Malić S
    J Med Chem; 2007 Aug; 50(17):4105-12. PubMed ID: 17672445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel thiophenes, thienopyrimidines, and triazolothienopyrimidines for the evaluation of anticancer and augmentation effects of gamma-radiation.
    Shaaban MA; Ghorab MM; Heiba HI; Kamel MM; Zaher NH; Mostafa MI
    Arch Pharm (Weinheim); 2010 Jul; 343(7):404-10. PubMed ID: 20379969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
    Gangjee A; Adair OO; Queener SF
    J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
    Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
    Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer activities of some newly synthesized pyridine, pyrane, and pyrimidine derivatives.
    Amr AG; Mohamed AM; Mohamed SF; Abdel-Hafez NA; Hammam Ael-F
    Bioorg Med Chem; 2006 Aug; 14(16):5481-8. PubMed ID: 16713269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line.
    Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents.
    Devegowda VN; Kim JH; Han KC; Yang EG; Choo H; Pae AN; Nam G; Choi KI
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1630-3. PubMed ID: 20138760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives.
    Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H
    Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrimidines. Part II: Synthesis of novel pyrimidines, 1,2,4-triazolo[4,3-a]pyrimidin-7-ones and pyrimidino[2,1-c][1,2,4]triazin-8-ones for their antimicrobial and anticancer activities.
    Habib NS; Soliman R; Ismail K; Hassan AM; Sarg MT
    Boll Chim Farm; 2003 Nov; 142(9):396-405. PubMed ID: 14971308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel 6-hydrazinyl-2,4-bismorpholino pyrimidine and 1,3,5-triazine derivatives as potential antitumor agents.
    Zhu W; Liu Y; Zhao Y; Wang H; Tan L; Fan W; Gong P
    Arch Pharm (Weinheim); 2012 Oct; 345(10):812-21. PubMed ID: 22707438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives and their anticancer activity.
    Kurumurthy C; Sambasiva Rao P; Veera Swamy B; Santhosh Kumar G; Shanthan Rao P; Narsaiah B; Velatooru LR; Pamanji R; Venkateswara Rao J
    Eur J Med Chem; 2011 Aug; 46(8):3462-8. PubMed ID: 21632155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis and SAR of 2-amino-pyrrolo[2,3-d]pyrimidines: a new class of Aurora-A kinase inhibitors.
    Moriarty KJ; Koblish HK; Garrabrant T; Maisuria J; Khalil E; Ali F; Petrounia IP; Crysler CS; Maroney AC; Johnson DL; Galemmo RA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5778-83. PubMed ID: 16949284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives.
    Kumar V; Madaan A; Sanna VK; Vishnoi M; Joshi N; Singh AT; Jaggi M; Sharma PK; Irchhaiya R; Burman AC
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1169-78. PubMed ID: 19555167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
    El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
    Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.